$25.9 Million is the total value of UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's 76 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VEA | VANGUARD FTSE DEV MKTSetfs | $3,384,000 | +3.4% | 75,430 | 0.0% | 13.06% | +66.6% | |
| VOO | VANGUARD 500 INDEX FUNDetfs | $3,053,000 | +6.3% | 12,446 | 0.0% | 11.79% | +71.3% | |
| VOE | VANGUARD MID-CAP VALUE ETFetfs | $3,031,000 | +5.6% | 27,165 | 0.0% | 11.70% | +70.2% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $2,840,000 | +9.7% | 524,929 | 0.0% | 10.96% | +76.9% | |
| VWO | VANGUARD MSCI EMERGING MKTSetfs | $2,665,000 | +5.4% | 58,049 | 0.0% | 10.29% | +69.8% | |
| VDE | VANGUARD ENERGY ETFetfs | $1,166,000 | +5.8% | 11,781 | 0.0% | 4.50% | +70.5% | |
| APEN | APOLLO ENDOSURGERY INC | $864,000 | +19.7% | 154,301 | 0.0% | 3.34% | +92.9% | |
| VNQ | VANGUARD REIT ETFetfs | $828,000 | -0.1% | 9,978 | 0.0% | 3.20% | +61.0% | |
| BPTH | BIO-PATH HOLDINGS INC | $766,000 | -44.5% | 3,830,882 | 0.0% | 2.96% | -10.5% | |
| PLXP | PLX PHARMA INC | $432,000 | +7.2% | 62,673 | 0.0% | 1.67% | +72.8% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $353,000 | -19.6% | 35,714 | 0.0% | 1.36% | +29.6% | |
| POR | PORTLAND GENERAL ELECTRIC CO | $5,000 | 0.0% | 118 | 0.0% | 0.02% | +58.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEXAS INSTRUMENTS INC | 41 | Q3 2023 | 31.2% |
| PORTLAND GENERAL ELECTRIC CO | 38 | Q3 2023 | 0.0% |
| LEXICON PHARMACEUTICALS INC | 33 | Q3 2023 | 1.7% |
| AEGLEA BIOTHERAPEUTICS INC | 27 | Q2 2023 | 11.0% |
| APOLLO ENDOSURGERY INC | 24 | Q1 2023 | 5.6% |
| PLX PHARMA INC | 23 | Q1 2023 | 1.7% |
| VANGUARD MSCI EMERGING MKTS | 22 | Q2 2019 | 10.3% |
| VANGUARD ENERGY ETF | 22 | Q2 2019 | 8.7% |
| VANGUARD S&P 500 ETF | 21 | Q3 2023 | 11.8% |
| VANGUARD MSCI EAFE ETF | 20 | Q2 2019 | 13.1% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Taysha Gene Therapies, Inc. | September 24, 2021 | 1,156,255 | 3.0% |
| ZIOPHARM ONCOLOGY INC | February 12, 2016 | 9 | 0.0% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-06-17 |
| 4 | 2024-06-12 |
| 4 | 2024-06-07 |
| 4/A | 2024-05-14 |
| 4 | 2024-05-01 |
| 3 | 2024-04-30 |
| 13F-HR | 2024-04-30 |
| 144 | 2024-04-29 |
| SC 13G | 2024-03-05 |
| 13F-HR | 2024-02-28 |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.